Delhi-based Varco Leg Care, a leading brand in leg health management, has successfully closed a Seed funding round, raising $500,000. The investment was led by Sunicon Maiden Fund, an early-stage venture fund associated with Sunicon Ventures.
This latest round adds to Varco Leg Care’s previously accumulated funds, totalling over Rs 4.5 crore ($370,000). The company’s valuation has surged by 2x within the past ten months, although specific figures remain undisclosed.
With this fresh capital injection, Varco Leg Care plans to enhance its operational capabilities on multiple fronts. These include expanding offline touchpoints, advancing research and development (R&D) initiatives, and scaling up marketing endeavours.
Varco Leg Care distinguishes itself by merging technology with clinical expertise to pioneer innovative leg care solutions. Its product range caters to diverse leg health issues such as varicose veins, diabetic foot, foot ulcers, and restless leg syndrome.
The company has witnessed remarkable growth, boasting a 110% increase in revenue over the past year. Since its establishment in 2022, Varco has served over 5 lakh customers and extended its footprint to over 3,000 medical stores across major Indian cities, including Mumbai, Bangalore, and Delhi.
Varco Leg Care’s products are available not only in brick-and-mortar stores like Guardian Pharmacy, Noble Plus, and Wellness Forever but also through online channels such as its website and popular marketplaces like Amazon, Flipkart, and 1mg.
This funding round marks a significant milestone for Varco Leg Care, which continues its mission to revolutionize leg health management and improve the lives of customers worldwide.
